New Search

Your search found 32 records, sorted by year and then date of acquisition.

1. Health-Related Quality of Life Among Prescription Opioid-Dependent Patients: Results from a Multi-Site Study. doc type
  Griffin, Margaret L. ; Bennett, Heather E. ; Fitzmaurice, Garrett M. ; Hill, Kevin P. ; Provost, Scott E. ; Weiss, Roger D.
 American Journal on Addictions 2015;24(4):308-314. [doi: 10.1111/ajad.12188].
 
2. Examining the Factor Structure of the Clinical Opiate Withdrawal Scale: A Secondary Data Analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. doc type
  Barbosa-Leiker, Celestina ; McPherson, Sterling ; Mamey, Mary Rose ; Burns, G. Leonard ; Layton, Matthew E. ; Roll, John M. ; Ling, Walter
 Drug and Alcohol Dependence 2015;152:218-222. [doi: 10.1016/j.drugalcdep.2015.03.036].
 
3. Denial of Urinalysis-Confirmed Opioid Use in Prescription Opioid Dependence. doc type
  Hilario, E. Yvette ; Griffin, Margaret L. ; McHugh, R. Kathryn ; McDermott, Katherine A. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):85-90. [doi: 10.1016/j.jsat.2014.07.003].
 
4. Using Behavioral Economics to Predict Opioid Use During Prescription Opioid Dependence Treatment. doc type
  Worley, Matthew J. ; Shoptaw, Steven J. ; Bickel, Warren K. ; Ling, Walter
 Drug and Alcohol Dependence 2015;148:62-68. [doi: 10.1016/j.drugalcdep.2014.12.018].
 
5. Assessing Craving and Its Relationship to Subsequent Prescription Opioid Use Among Treatment-Seeking Prescription Opioid Dependent Patients. doc type
  McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Carroll, Kathleen M. ; Griffin, Margaret L. ; Hill, Kevin P. ; Wasan, Ajay D. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2014;145:121-126. [doi: 10.1016/j.drugalcdep.2014.10.002].
 
6. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
7. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
8. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
9. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
10. Concurrent Substance Abuse is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence. doc type
  Meade, Christina S. ; Bevilacqua, Lisa A. ; Moore, Elizabeth D. ; Griffin, Margaret L. ; Gardin, John G. II ; Potter, Jennifer Sharpe ; Hatch-Maillette, Mary A. ; Weiss, Roger D.
 American Journal on Addictions 2014;23(1):27-33. [doi: 10.1111/j.1521-0391.2013.12057.x].
 
11. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
12. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
13. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
14. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
15. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
16. Missing Data in Substance Abuse Treatment Research: Current Methods and Modern Approaches. doc type
  McPherson, Sterling ; Barbosa-Leiker, Celestina ; Burns, G. Leonard ; Howell, Donelle ; Roll, John M.
 Experimental and Clinical Psychopharmacology 2012;20(3):243-250. [doi: 10.1037/a0027146].
 
17. Alcohol and Drug Dependence Symptom Items as Brief Screeners for Substance Use Disorders: Results from the Clinical Trials Network. doc type
  Wu, Li-Tzy ; Blazer, Dan G. ; Woody, George E. ; Burchett, Bruce ; Yang, Chongming ; Pan, Jeng-Jong ; Ling, Walter
 Journal of Psychiatric Research 2012;46(3):360-369. [doi: 10.1016/j.jpsychires.2011.12.002].
 
18. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
19. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
20. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
21. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
22. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
23. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
24. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
25. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
26. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
27. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
28. Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. doc type
  Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
29. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
30. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
31. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
32. Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search